Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 19, 2026

Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor
07:21

Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor

Published on: May 2, 2022

Gastrointestinal stromal tumor.

Xiaohui Zhao, Changjun Yue

    Journal of Gastrointestinal Oncology
    |September 4, 2012
    PubMed
    Summary

    Gastrointestinal stromal tumors (GIST) are now well-defined due to discoveries in KIT and PDGFRA gene mutations, leading to better diagnosis and treatment strategies. This review covers GIST

    Related Concept Videos

    The Tumor Microenvironment02:17

    The Tumor Microenvironment

    Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Abnormal Eosinophils With Large, Distinctly Basophilic Granules (Harlequin Cells) on Peripheral Blood Smear: A Clue for Diagnosing Chronic Myeloid Leukemia.

    Journal of hematology·2026
    Same author

    Genomic imprinting biomarkers for cervical cancer risk stratification.

    Cancer communications (London, England)·2024
    Same author

    Rhodiosin from Rhodiola crenulata effectively alleviate postprandial hyperglycemia by inhibiting both the activity and production of α‑glucosidase.

    Phytomedicine : international journal of phytotherapy and phytopharmacology·2024
    Same author

    Excess healthcare resource utilization and costs for commercially insured patients with pulmonary arterial hypertension: A real-world data analysis.

    Pulmonary circulation·2024
    Same author

    Contrast‑associated acute kidney injury in myocardial infarction patients undergoing elective percutaneous coronary intervention: insight from the Iodixanol-AKI Registry.

    Internal and emergency medicine·2024
    Same author

    Soybean hypocotyl elongation is regulated by a MYB33-SWEET11/21-GA2ox8c module involving long-distance sucrose transport.

    Plant biotechnology journal·2024

    Area of Science:

    • Gastrointestinal Oncology
    • Molecular Pathology
    • Gastrointestinal Stromal Tumors (GIST)

    Background:

    • Gastrointestinal stromal tumors (GIST) are the most common gastrointestinal mesenchymal neoplasms.
    • Historically poorly understood, GISTs are now well-defined entities.
    • Recent advances highlight unique biologic behavior, clinicopathological features, and molecular mechanisms.

    Purpose of the Study:

    • To provide a comprehensive review of Gastrointestinal Stromal Tumors (GIST).
    • To discuss the evolution of GIST understanding from a poorly understood neoplasm to a defined tumor entity.
    • To cover historical aspects, epidemiology, pathogenesis, genetics, diagnosis, prognostic factors, and treatment strategies.

    Main Methods:

    • Literature review encompassing historical data, epidemiology, and molecular pathogenesis.
    • Analysis of diagnostic methodologies including histology, immunohistochemistry, and molecular analysis.
    • Review of risk stratification and current treatment strategies for GIST.

    Main Results:

    • Discovery of KIT and PDGFRA gene mutations has significantly advanced GIST understanding.
    • Diagnosis relies on integrated histology, immunohistochemistry, and molecular analysis.
    • Pathological evaluation is crucial for risk assessment and clinical management.

    Conclusions:

    • Understanding GIST biology at the molecular level has paved the way for novel treatment modalities.
    • Accurate diagnosis and risk assessment are essential for effective GIST management.
    • Continued research into molecular mechanisms promises further therapeutic advancements.
    Keywords:
    GISTGastrointestinal stromal tumorKIT mutationimatinib

    Related Experiment Videos

    Last Updated: May 19, 2026

    Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor
    07:21

    Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor

    Published on: May 2, 2022